Evaluating the Role of Inflammation in Chronic Airways Disease: The ERICA Study

References

• Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157(6 Pt 1):1791–1797.
   PubMed Web of Science ®Google Scholar
• Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Euro Respir J 2010; 36(1):81–88.
   PubMed Web of Science ®Google Scholar
• Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, Quadriceps wasting and physical inactivity in patients with COPD. ERJ 2012; 40(5):1115–1122.
   PubMed Web of Science ®Google Scholar
• McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176(12):1208–1214.
   PubMed Web of Science ®Google Scholar
• Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175(12):1259–1265.
   PubMed Web of Science ®Google Scholar
• Bolton CE, Ionescu AA, Shiels KM, Pettit RJ, Edwards PH, Stone MD, Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170(12):1286–93.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006; 100(1):115–122.
   PubMed Web of Science ®Google Scholar
• Sidney S, Sorel M, Quesenberry CP, Jr., DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128(4):2068–2075.
   PubMed Web of Science ®Google Scholar
• Natanek SA, Gosker HR, Slot IG, Marsh GS, Hopkinson NS, Man WD, Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine? Muscle Nerve 2013; 48(4):488–497.
   PubMed Web of Science ®Google Scholar
• Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62(2):115–120.
   PubMed Web of Science ®Google Scholar
• Gea J, Agusti A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol 2013; 114(9):1222–1234.
   PubMed Web of Science ®Google Scholar
• Troosters T, Gosselink R, Decramer M. Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000; 109(3):207–212.
   PubMed Web of Science ®Google Scholar
• Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140(2):331–342.
   PubMed Web of Science ®Google Scholar
• Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PloS One 2012; 7(5):e37483.
   PubMed Web of Science ®Google Scholar
• Duvoix A, Dickens J, Haq I, Mannino D, Miller B, Tal-Singer R, Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax 2013; 68:670–676.
   PubMed Web of Science ®Google Scholar
• Valvi D, Mannino DM, Mullerova H, Tal-Singer R. Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts. Int J Chron Obstruct Pulmon Dis 2012; 7:173–182.
   PubMed Web of Science ®Google Scholar
• Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186(10):982–988.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363(12):1128–1138.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). European Respir J 2008; 31(4):869–873.
   PubMed Web of Science ®Google Scholar
• Gale NS, Munnery M, Albarrati A, Munnery I, Shale DJ, Cockcroft JR. Assessment of risk factors in chronic airways disease evaluation (ARCADE). Artery Res 2012; 6(4):158.
   Google Scholar
• Casaburi R, Celli B, Crapo J, Criner G, Croxton T, Gaw A, The COPD Biomarker Qualification Consortium (CBQC). J COPD. 2013; 10(3):367–377.
   PubMedGoogle Scholar
• Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012; 367(14):1310–1320.
   PubMed Web of Science ®Google Scholar
• Clauss A. [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 1957; 17(4):237–246.
   PubMedGoogle Scholar
• Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR, Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998; 16(12 Pt 2):2079–2084.
   PubMed Web of Science ®Google Scholar
• Csanyi A, Egervari A. Simple clinical method of average intima-media thickness measurement in the common carotid artery. VASA Zeitschrift fur Gefasskrankheiten 1996;25(3):242–248.
   PubMedGoogle Scholar
• ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111–117.
   PubMed Web of Science ®Google Scholar
• Edwards RH, Young A, Hosking GP, Jones DA. Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med 1977; 52(3):283–290.
   PubMedGoogle Scholar
• Steiner MC, Roubenoff R, Tal-Singer R, Polkey MI. Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review. Thorax 2012; 67(12):1102–1109.
   PubMed Web of Science ®Google Scholar
• Maclay JD, McAllister DA, Mills NL, Paterson FP, Ludlam CA, Drost EM, Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(6):513–520.
   PubMed Web of Science ®Google Scholar
• MacNee W. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. Ann Med 2013; 45(3):291–300.
   PubMed Web of Science ®Google Scholar
• Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res 2011; 12:146.
   PubMed Web of Science ®Google Scholar
• Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178(12):1211–1218.
   PubMed Web of Science ®Google Scholar
• Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 2012; 106(4):522–530.
   PubMed Web of Science ®Google Scholar
• Moore AJ, Soler RS, Cetti EJ, Amanda Sathyapala S, Hopkinson NS, Roughton M, Sniff nasal inspiratory pressure versus IC/TLC ratio as predictors of mortality in COPD. Respir Med. 2010; 104(9):1319–1325.
   PubMed Web of Science ®Google Scholar
• Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49(2):M85–94.
   PubMedGoogle Scholar
• Kon SS, Patel MS, Canavan JL, Clark AL, Jones SE, Nolan CM, Reliability and validity of the four metre gait speed in COPD. ERJ 2013; 42(2):333–340.
   PubMed Web of Science ®Google Scholar